ethyl ((3,4,5-trimethoxybenzoyl)amino)acetate | 92502-39-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: ethyl ((3,4,5-trimethoxybenzoyl)amino)acetate
• 英文别名: N-(3,4,5-trimethoxy-benzoyl)-glycine ethyl ester；N-(3,4,5-Trimethoxy-benzoyl)-glycin-aethylester；(3.4.5-Trimethoxy-benzamino)-essigsaeure-aethylester；N-<3.4.5-Trimethoxy-benzoyl>-glycin-aethylester；N-Galloylglycinaethylester；(3,4,5-Trimethoxy-benzoylamino)-acetic acid ethyl ester；ethyl 2-[(3,4,5-trimethoxybenzoyl)amino]acetate
• CAS: 92502-39-1
• 化学式: C₁₄H₁₉NO₆
• 分子量: 297.308
• InChiKey: LOGFEAQZRBDVIG-UHFFFAOYSA-N

物化性质

• 熔点：
  109 °C
• 沸点：
  389.6±42.0 °C(Predicted)
• 密度：
  1.166±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  21
• 可旋转键数：
  8
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  83.1
• 氢给体数：
  1
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  ethyl ((3,4,5-trimethoxybenzoyl)amino)acetate 生成 (3,4,5-三甲氧基苯甲酰基)氨基]乙酸
  参考文献：
  名称：

  Sugasawa, Yakugaku Zasshi/Journal of the Pharmaceutical Society of Japan, 1935, vol. 55, p. 224,228; engl. Ref. S. 58, 59

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4,5-三甲氧基苯甲酸 在 N,N-二甲基甲酰胺 草酰氯 、 N,N-二异丙基乙胺 作用下， 以 二氯甲烷 为溶剂， 生成 ethyl ((3,4,5-trimethoxybenzoyl)amino)acetate
  参考文献：
  名称：

  Novel Heterobivalent Tacrine Derivatives as Cholinesterase Inhibitors with Notable Selectivity Toward Butyrylcholinesterase

  摘要：

  Two series of novel heterobivalent tacrine derivatives were synthesized. A trimethoxy substituted benzene was linked to the tacrine moiety by a hydrazide-based linker. The compounds were evaluated as cholinesterase inhibitors, and trimethoxybenzoic acid derivatives with 11- or 12-atom spacers were the most potent inhibitors of human acetylcholinesterase. The inhibitors showed a surprising selectivity toward human butyrylcholinesterase, where several trimethoxyphenylpropionic acid derivatives had IC50 values less than 250 mu M.

  DOI：

  10.1021/jm060742o

文献信息

• Therapy for urolithiasis with hydroxamic acids. I. Synthesis of new N-(aroyl)glycinohydroxamic acid derivatives and related compounds.
  作者：KEIICHI MUNAKATA、SATORU TANAKA、SHOJI TOYOSHIMA

  DOI：10.1248/cpb.28.2045

  日期：——

  With the aim of finding a therapeutic agent for urolithiasis, forty-three new N-(aroyl)-glycinohydroxamic acid derivatives and related compounds were synthesized and examined for urease inhibitory activity. Their urinary excretion in rats was also determined.

  为了寻找针对尿路结石的治疗药物，我们合成了四十三种新的N-(芳酰基)-甘氨酸羟肟酸衍生物及相关化合物，并检测了它们的脲酶抑制活性。同时，我们还确定了这些化合物在大鼠体内的尿液排泄情况。
• [EN] COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS<br/>[FR] COMPOSÉS POUR LE TRAITEMENT D'INFECTIONS VIRALES PAR PARAMYXOVIRUS
  申请人：ALIOS BIOPHARMA INC

  公开号：WO2014031784A1

  公开（公告）日：2014-02-27

  Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

  本文披露了新的抗病毒化合物，以及包含一种或多种抗病毒化合物的药物组合物，并且揭示了合成这些化合物的方法。本文还披露了利用一种或多种小分子化合物改善和/或治疗副黏病毒病毒感染的方法。副黏病毒感染的例子包括由人类呼吸道合胞病毒（RSV）引起的感染。
• Copper-Catalyzed Aerobic Oxidative [2 + 3] Cyclization/Aromatization Cascade Reaction: Atom-Economical Access to Tetrasubstituted 4,5-Biscarbonyl Imidazoles
  作者：Jialin Xie、Yuanqiong Huang、Hongjian Song、Yuxiu Liu、Qingmin Wang

  DOI：10.1021/acs.orglett.7b02767

  日期：2017.11.17

  An atom-economical method for accessing tetrasubstituted 4,5-biscarbonylimidazoles by reaction between glycine derivatives and 5-alkoxyoxazoles is reported. The method, which involves a copper-catalyzed aerobic oxidative [2 + 3] cyclization/aromatization cascade process, starts from readily available and inexpensive materials, uses molecular oxygen as a co-oxidant, and has a broad substrate scope.

  报道了通过甘氨酸衍生物和5-烷氧基恶唑之间的反应获得四取代的4，5-双羰基咪唑的原子经济方法。该方法涉及铜催化的好氧氧化[2 + 3]环化/芳香化反应级联过程，从容易获得且廉价的材料开始，使用分子氧作为助氧化剂，具有广泛的底物范围。
• COMPOUNDS FOR THE TREATMENT OF PARAMOXYVIRUS VIRAL INFECTIONS
  申请人：Alios Bio Pharma, Inc.

  公开号：US20150238498A1

  公开（公告）日：2015-08-27

  Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

  本文披露了一些新的抗病毒化合物，以及包含一种或多种抗病毒化合物的药物组合物和合成它们的方法。还披露了使用一种或多种小分子化合物改善和/或治疗副黏液病毒病毒感染的方法。副黏液病毒感染的例子包括由人类呼吸道合胞病毒(RSV)引起的感染。
• Compounds for the treatment of paramyxovirus viral infections
  申请人：JANSSEN BIOPHARMA, INC.

  公开号：US11014935B2

  公开（公告）日：2021-05-25

  Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. Examples of paramyxovirus infection include an infection caused by human respiratory syncytial virus (RSV).

  本文公开了新的抗病毒化合物，以及包括一种或多种抗病毒化合物的药物组合物和合成这些化合物的方法。本文还公开了用一种或多种小分子化合物改善和/或治疗副黏液病毒感染的方法。副粘病毒感染的例子包括由人类呼吸道合胞病毒（RSV）引起的感染。